Pharmaceuticals in the Aquatic Environment: a Short Summary of Current Knowledge and the Potential Impacts on Aquatic Biota and Humans

Gillian McEniff, Wiebke Schmidt, Brian Quinn

Research output: Book/ReportCommissioned report

33 Downloads (Pure)

Abstract

Reports concerning the quantitative analysis of pharmaceuticals in marine ecosystems are somewhat limited. With an increasing human population in coastal regions, elevated levels of anthropogenic pollution can be anticipated. The detection of novel contaminants, such as human pharmaceuticals in marine and coastal waters, is a new challenge. The knowledge of the potential toxicological effects of these novel contaminants in non-target organisms remains incomplete. It is necessary to determine pharmaceutical fate and assess any potential risk of exposure for aquatic species and, ultimately, for seafood consumers.

However, in Ireland, very little research has been carried out to determine the presence of pharmaceutical residues in the aquatic environment. This report aims to collate the knowledge base by documenting what is currently known and understood about pharmaceuticals in the aquatic environment and their potential impacts on aquatic biota and ultimately humans. This summary document provides the background for a larger and more detailed report entitled ‘The assessment and potential human impact of exposure to environmental contaminants on marine and freshwater bivalves’ derived from a five-year, EPA-funded Developing Environmental Research Potential (DERP) study (2007-DRP-3), available for download at http://erc.epa.ie/safer/.
Original languageEnglish
Place of PublicationDublin
PublisherEnvironmental Protection Agency
Commissioning bodyEnvironmental Protection Agency (EPA) Ireland
Number of pages52
Volume142
ISBN (Print)978-1-84095-579-8
Publication statusPublished - 2015

Fingerprint

aquatic environment
biota
drug
pollutant
nontarget organism
seafood
environmental research
marine ecosystem
anthropogenic effect
quantitative analysis
bivalve
coastal water
pollution
exposure

Keywords

  • Pharmaceuticals
  • Environment
  • Pollution

Cite this

@book{8eda367248ad40729901328e9dcf4187,
title = "Pharmaceuticals in the Aquatic Environment: a Short Summary of Current Knowledge and the Potential Impacts on Aquatic Biota and Humans",
abstract = "Reports concerning the quantitative analysis of pharmaceuticals in marine ecosystems are somewhat limited. With an increasing human population in coastal regions, elevated levels of anthropogenic pollution can be anticipated. The detection of novel contaminants, such as human pharmaceuticals in marine and coastal waters, is a new challenge. The knowledge of the potential toxicological effects of these novel contaminants in non-target organisms remains incomplete. It is necessary to determine pharmaceutical fate and assess any potential risk of exposure for aquatic species and, ultimately, for seafood consumers.However, in Ireland, very little research has been carried out to determine the presence of pharmaceutical residues in the aquatic environment. This report aims to collate the knowledge base by documenting what is currently known and understood about pharmaceuticals in the aquatic environment and their potential impacts on aquatic biota and ultimately humans. This summary document provides the background for a larger and more detailed report entitled ‘The assessment and potential human impact of exposure to environmental contaminants on marine and freshwater bivalves’ derived from a five-year, EPA-funded Developing Environmental Research Potential (DERP) study (2007-DRP-3), available for download at http://erc.epa.ie/safer/.",
keywords = "Pharmaceuticals, Environment, Pollution",
author = "Gillian McEniff and Wiebke Schmidt and Brian Quinn",
year = "2015",
language = "English",
isbn = "978-1-84095-579-8",
volume = "142",
publisher = "Environmental Protection Agency",
address = "Ireland",

}

Pharmaceuticals in the Aquatic Environment : a Short Summary of Current Knowledge and the Potential Impacts on Aquatic Biota and Humans. / McEniff, Gillian; Schmidt, Wiebke; Quinn, Brian.

Dublin : Environmental Protection Agency, 2015. 52 p.

Research output: Book/ReportCommissioned report

TY - BOOK

T1 - Pharmaceuticals in the Aquatic Environment

T2 - a Short Summary of Current Knowledge and the Potential Impacts on Aquatic Biota and Humans

AU - McEniff, Gillian

AU - Schmidt, Wiebke

AU - Quinn, Brian

PY - 2015

Y1 - 2015

N2 - Reports concerning the quantitative analysis of pharmaceuticals in marine ecosystems are somewhat limited. With an increasing human population in coastal regions, elevated levels of anthropogenic pollution can be anticipated. The detection of novel contaminants, such as human pharmaceuticals in marine and coastal waters, is a new challenge. The knowledge of the potential toxicological effects of these novel contaminants in non-target organisms remains incomplete. It is necessary to determine pharmaceutical fate and assess any potential risk of exposure for aquatic species and, ultimately, for seafood consumers.However, in Ireland, very little research has been carried out to determine the presence of pharmaceutical residues in the aquatic environment. This report aims to collate the knowledge base by documenting what is currently known and understood about pharmaceuticals in the aquatic environment and their potential impacts on aquatic biota and ultimately humans. This summary document provides the background for a larger and more detailed report entitled ‘The assessment and potential human impact of exposure to environmental contaminants on marine and freshwater bivalves’ derived from a five-year, EPA-funded Developing Environmental Research Potential (DERP) study (2007-DRP-3), available for download at http://erc.epa.ie/safer/.

AB - Reports concerning the quantitative analysis of pharmaceuticals in marine ecosystems are somewhat limited. With an increasing human population in coastal regions, elevated levels of anthropogenic pollution can be anticipated. The detection of novel contaminants, such as human pharmaceuticals in marine and coastal waters, is a new challenge. The knowledge of the potential toxicological effects of these novel contaminants in non-target organisms remains incomplete. It is necessary to determine pharmaceutical fate and assess any potential risk of exposure for aquatic species and, ultimately, for seafood consumers.However, in Ireland, very little research has been carried out to determine the presence of pharmaceutical residues in the aquatic environment. This report aims to collate the knowledge base by documenting what is currently known and understood about pharmaceuticals in the aquatic environment and their potential impacts on aquatic biota and ultimately humans. This summary document provides the background for a larger and more detailed report entitled ‘The assessment and potential human impact of exposure to environmental contaminants on marine and freshwater bivalves’ derived from a five-year, EPA-funded Developing Environmental Research Potential (DERP) study (2007-DRP-3), available for download at http://erc.epa.ie/safer/.

KW - Pharmaceuticals

KW - Environment

KW - Pollution

M3 - Commissioned report

SN - 978-1-84095-579-8

VL - 142

BT - Pharmaceuticals in the Aquatic Environment

PB - Environmental Protection Agency

CY - Dublin

ER -